[김창수의 e뉴스 브리핑] Yuhan Corporation to invest 10 billion won in April Bio… 2nd major shareholder registration, etc.
[김창수의 e뉴스 브리핑] Chong Kun Dang’Napa Beltan’ applied for conditional permission for corona treatment, etc.
[김창수의 e뉴스 브리핑] Celltrion’Rekirona’ initiated emergency use review before product approval by the European Medicines Agency, etc.
[김창수의 e뉴스 브리핑] Artenex “FDA demands supplementation of marketing permission for’Oraxol’”… Misapproval
[김창수의 e뉴스 브리핑] Celltrion corona treatment’Recyrona’, initiated a preliminary review of the product approval of the European Medicines Agency
[김창수의 e뉴스 브리핑] Korea-US NASH innovative new drug, Korea New Drug Development Award Technology Export Award, etc.
[김창수의 e뉴스 브리핑] Celltrion antibody treatment’Rekirona’ started supplying nationwide medical institutions
![[김창수의 e뉴스 브리핑] Yuhan Corporation to invest 10 billion won in April Bio… 2nd major shareholder registration, etc.](https://www.fetv.co.kr/data/photos/20210312/art_16164856998123_8290ba.jpg "[김창수의 e뉴스 브리핑] Yuhan Corporation to invest 10 billion won in April Bio… 2nd major shareholder registration, etc.")
![[김창수의 e뉴스 브리핑] Chong Kun Dang’Napa Beltan’ applied for conditional permission for corona treatment, etc.](https://www.fetv.co.kr/data/photos/20210310/art_1615189269477_15a586.png "[김창수의 e뉴스 브리핑] Chong Kun Dang’Napa Beltan’ applied for conditional permission for corona treatment, etc.")
![[김창수의 e뉴스 브리핑] Celltrion’Rekirona’ initiated emergency use review before product approval by the European Medicines Agency, etc.](https://www.fetv.co.kr/data/photos/20210309/art_16147568638222_61ca43.png "[김창수의 e뉴스 브리핑] Celltrion’Rekirona’ initiated emergency use review before product approval by the European Medicines Agency, etc.")
![[김창수의 e뉴스 브리핑] Artenex “FDA demands supplementation of marketing permission for’Oraxol’”… Misapproval](https://www.fetv.co.kr/data/photos/20210309/art_16146713187514_5bf575.jpg "[김창수의 e뉴스 브리핑] Artenex “FDA demands supplementation of marketing permission for’Oraxol’”… Misapproval")
![[김창수의 e뉴스 브리핑] Celltrion corona treatment’Recyrona’, initiated a preliminary review of the product approval of the European Medicines Agency](https://www.fetv.co.kr/data/photos/20210208/art_16142395142854_69ee58.png "[김창수의 e뉴스 브리핑] Celltrion corona treatment’Recyrona’, initiated a preliminary review of the product approval of the European Medicines Agency")
![[김창수의 e뉴스 브리핑] Korea-US NASH innovative new drug, Korea New Drug Development Award Technology Export Award, etc.](https://www.fetv.co.kr/data/photos/20210208/art_1613980517598_364b1d.jpg "[김창수의 e뉴스 브리핑] Korea-US NASH innovative new drug, Korea New Drug Development Award Technology Export Award, etc.")
![[김창수의 e뉴스 브리핑] Celltrion antibody treatment’Rekirona’ started supplying nationwide medical institutions](https://www.fetv.co.kr/data/photos/20210207/art_1613548216527_9f705e.jpg "[김창수의 e뉴스 브리핑] Celltrion antibody treatment’Rekirona’ started supplying nationwide medical institutions")